Cannon Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
BBA
Cannon Advisors's INSM Position: Q3 2026 in Review
Cannon Advisors increased its Insmed (INSM) stake by 20% in Q3 2026, buying an estimated $142K and bringing the position to 7,220 shares worth $699K. The position accounts for 0.41% of the portfolio, ranked #63.
Cannon Advisors first reported a position in INSM in Q2 2026 and has held it in 2 quarters since. 703 funds tracked by Wall St. Rank hold INSM as of Q3 2026.
- Cannon Advisors held 7,220 shares of Insmed worth $699K as of Q3 2026.
- Cannon Advisors bought 1,202 Insmed shares in Q3 2026, an estimated $142K.
- Insmed made up 0.41% of Cannon Advisors's portfolio in Q3 2026, its #63 holding.
- Cannon Advisors first reported a position in Insmed in Q2 2026 and has held it in 2 quarters since.
- 703 funds tracked by Wall St. Rank held Insmed as of Q3 2026.
Based on Cannon Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.